PR News

BOCA RATON, FL / ACCESSWIRE / August 6, 2024 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), one of...

Second quarter net income of $7.7 million Second quarter adjusted EBITDA of $25.8 million Dredging backlog of $807.9 million at June 30,...

SHANGHAI, China, Aug. 07, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a...

  PITTSBURGH, Aug. 06, 2024 (GLOBE NEWSWIRE) --  L.B. Foster Company (Nasdaq: FSTR), a global technology solutions provider of products and...

– Phase 3 LUGANO pivotal non-inferiority clinical trial of DURAVYU™ in wet AMD on track for first patient dosing in...

Announces New Actions to Accelerate Transformation Second quarter 2024 highlights(1) compared to Q2 2023: Net revenue from continuing operations of...

Revenue Growth in-line With Previous Outlook With 29% Year-over-Year Growth in SaaS ARR Contacts Investor Relations Stan Kovler 919/595-4196 Investor_relations@extremenetworks.com...

ATHENS, Greece, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator...

The Independent Data Monitoring Committee (IDMC) recommended continuation of the clinical trial based on safety assessment and pre-determined futility and...

INITIAL PRODUCTS TO BE SOLD INCLUDE CHEMICAL MECHANICAL PLANARIZATION (CMP) SOLUTIONS FOR SILICON CARBIDE (SiC) APPLICATIONS Contacts Media: Connie Chandler...

All of the amounts disclosed in this press release are in U.S. dollars unless otherwise notedTEL AVIV, Israel, Aug. 07,...

-- Today announced promising initial data from Phase 1 clinical trial of EO-3021; 42.8% confirmed ORR observed in Claudin 18.2-enriched...

Edgio’s extensive development pipeline and cadence solidifies the company’s position in the Leaders circle Contacts Media: Patti Moran, Edgio pmoran@edg.io...

On track to present additional clinical data from the RUBY trial and the EdiTHAL trial by year-endIn vivo preclinical proof-of-concept...

Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDTLYON, France, August 7, 2024 -- EDAP...

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D., has...

PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions...

Investment HighlightsDALLAS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (Nasdaq: CSWI) today announced the strategic acquisition of PSP...

- Revenue of $119.4 Million - - Additional Quarter of Positive Cash Flow From Operations of $10.0 Million - -...

LEHI, Utah, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading...

GUELPH, ON, Aug. 7, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced that...

Future-forward transformation unifies portfolios, drives growth and boosts customer experience with the power of AI Contacts CSG Kristine Østergaard Public...

SAN JOSE, Calif., Aug. 6, 2024  /PRNewswire/ -- Cisco (NASDAQ: CSCO) has scheduled a conference call for Wednesday, Aug 14,...

Significant Penetration into Private Networks Management Reiterates Full-Year 2024 Outlook  ROSH HA'AIN, Israel, Aug. 7, 2024 /PRNewswire/ -- Ceragon (NASDAQ:...

LOUISVILLE, Ky., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX, CREXW),...

NORWOOD, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today provided...

SUMMIT, PEAK and APEX registration-directed clinical trial enrollment remains on track; topline results expected from all three studies in 2025Ended...

Contacts Investor and Media Contacts Philip Kranz, Investor Relations +1 217-238-8480 Philip.kranz@consolidated.com Jennifer Spaude, Media Relations +1 507-386-3765 Jennifer.spaude@consolidated.com Consolidated...

Vancouver, Canada, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...

NEW YORK, 07 août 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique,...

TULSA, Okla., Aug. 6, 2024 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the "Company"), an emerging leader in...

New AI tool simplifies counting inspections for manufacturers across all industries NATICK, Mass., Aug. 6, 2024 /PRNewswire/ -- Cognex Corporation...

Early results of a novel weed management solution using two herbicides show promise.The first known use of stacked gene edited...

PHILADELPHIA, Aug. 6, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering...

Generated Robust 28% Year-over-Year Revenue Growth in Q2 2024Recorded Positive Quarterly Net Income for Third Consecutive Quarter, and Positive Adjusted...

NovAliX is a drug discovery focused CRO with award-winning chemistry teams and one of the world’s most comprehensive biophysics platforms....

Generated total revenues of $929 million, an increase of 56% from the prior-year period; reduced GAAP operating loss and achieved...

SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and...

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey...

Four abstracts containing data updates across clinical pipeline accepted for poster presentation at ESMO Congress 2024 Focused R&D pipeline on...